We found that the SCRIB gene is amplified in 14.42% of breast cancer patients in the TCGA dataset, and the gene amplification correlates with SCRIB mRNA expression in the TCGA breast cancer dataset (Supplementary Fig. 1a). This evidence concerns the gene SCRIB and breast cancer.